HiveProspectStranded Biotech Asset IntelligenceResearch intelligence
Research workspace tools

Atorvastatin

WITHDRAWN · PHASE4 · Atherosclerosis

The study chair changed his employment, the realization of the study was not possible

Registry source

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.